Literature DB >> 20879883

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Giovanni Targher1, Christopher P Day, Enzo Bonora.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20879883     DOI： 10.1056/NEJMra0912063

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  597 in total

1.  Assessment of endothelial function in patients with nonalcoholic fatty liver disease.

Authors:  Yasar Colak; Ebubekir Senates; Atakan Yesil; Yusuf Yilmaz; Oguzhan Ozturk; Levent Doganay; Ender Coskunpinar; Ozlem Timirci Kahraman; Banu Mesci; Celal Ulasoglu; Ilyas Tuncer
Journal:  Endocrine       Date:  2012-06-03       Impact factor: 3.633

2.  Lifestyle Interventions Beyond Diet and Exercise for Patients With Nonalcoholic Fatty Liver Disease.

Authors:  James Philip Esteban; Amreen Dinani
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-03

3.  52-year-old man with liver enzyme abnormalities and elevated ferritin level.

Authors:  Eric M Nelsen; Darrell B Newman; Seth Sweetser
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

4.  Gallstone disease is associated with increased mortality in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2010-11-11       Impact factor: 22.682

5.  Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.

Authors:  Jeffrey C Sirota; Kim McFann; Giovanni Targher; Richard J Johnson; Michel Chonchol; Diana I Jalal
Journal:  Metabolism       Date:  2012-10-02       Impact factor: 8.694

Review 6.  Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Xue-Qun Zhang; Cheng-Fu Xu; Chao-Hui Yu; Wei-Xing Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 7.  Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Authors:  Stefano Ballestri; Amedeo Lonardo; Stefano Bonapace; Christopher D Byrne; Paola Loria; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 8.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

9.  Quantum coherence spectroscopy to measure dietary fat retention in the liver.

Authors:  Lucas Lindeboom; Robin A de Graaf; Christine I Nabuurs; Petronella A van Ewijk; Matthijs Kc Hesselink; Joachim E Wildberger; Patrick Schrauwen; Vera B Schrauwen-Hinderling
Journal:  JCI Insight       Date:  2016-08-18

10.  Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women.

Authors:  Jennifer L Rehm; Peter M Wolfgram; Diego Hernando; Jens C Eickhoff; David B Allen; Scott B Reeder
Journal:  Eur Radiol       Date:  2015-04-28       Impact factor: 5.315
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.